Lisa Brockway

How to address barriers to clinical trial patient recruitment [update]

[Updated June 2019]

Continue reading

Webinar Recap: Precision Recruitment

With clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for and interested in a particular clinical trial. Traditional methods of recruitment are becoming less impactful, which is why it’s time to consider a new approach: precision recruitment.

Continue reading

The Next Phase of Faster Clinical Trial Patient Recruitment

For years, clinical trial patient recruitment has looked the same: identify eligibility criteria for a single trial, conduct traditional media outreach, screen patients for that trial, and hope for the best. Increasingly, however, sponsors have been turning to technology, getting more specific in their outreach and therefore becoming more successful in their recruiting not just for one trial, but ...

Continue reading

5 Benefits of Faster Clinical Trial Patient Recruitment

One of the most frustrating elements of medical research today is the speed — patients need new treatments now, but often, clinical trials are delayed or closed due to difficulty finding patients to take part. With clinical trial patient recruitment, sponsors can not only meet deadlines, but beat them, bringing new treatments to patients faster. Here, we break down the key reasons to set your ...

Continue reading

Antidote and the American Liver Foundation (ALF) announce partnership to accelerate liver disease research

Today, liver disease affects 30 million people in the US — one in 10 Americans. And unfortunately, that number is on the rise. To address this head-on, more research is required. And of course, that involves more clinical trial volunteers.

Continue reading

Scrip Awards: Antidote’s Work Connecting Patients to Research Studies is Recognized

If you’ve been diagnosed with an illness, you probably know the accompanying feeling of uncertainty all too well. How will this impact your life? What treatment will you select? Will there be side effects? Will it work?

Continue reading

Scrip Awards: Antidote Named as Finalist in Technology and Partnerships Categories

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for ...

Continue reading

Scrip Awards: JDRF and Antidote Collaborate to Connect Patients to Research Studies

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are now finalists for two Scrip Awards. The Scrip Awards provide the industry with the opportunity to recognize its highest achievers across the drug development spectrum— from novel deals, to new drug launches, to technological breakthroughs in clinical ...

Continue reading

Diabetes Awareness Month: The Latest in Diabetes Research

National Diabetes Awareness Month is a time to drive awareness of the disease – what it’s like to live with it, what’s the best way to treat it right now, and what research is happening that can give us a glimpse of the future of diabetes treatment and care.

Continue reading

Lupus Research Alliance and Antidote partner to accelerate lupus research

Today, we are pleased to announce a new partnership with the Lupus Research Alliance to help lupus patients and their loved ones find and understand their clinical trial options in a new way. Right now, there are more than 120 clinical studies for lupus, and they need more than 35,000 people to take part. It’s only by increasing the number of patients getting involved in research that we can ...

Continue reading

Get our latest posts in your inbox